Skip to main content
. 2019 Apr 10;3(5):1039–1052. doi: 10.1210/js.2019-00122

Table 3.

Autoimmune Disorders in Patients With CAH Due to 21OHD Divided Into Phenotypes and Compared With Age- and Sex-Matched Controls (100 Controls Per Case)

Variable SW SV NC
All (n = 288) Female Patients (n = 157) Male Patients (n = 131) All (n = 188) Female Patients (n = 101) Male Patients (n = 87) All (n = 90) Female Patients (n = 67) Male Patients (n = 23)
Mean age ± SD, y 24.5 ± 16.1 25.3 ± 15.6 23.6 ± 16.7 32.5 ± 19.3 32.2 ± 17.5 32.8 ± 21.3 29.3 ± 15.9 30.2 ± 15.7 26.7 ± 16.4
Any autoimmune disorder 12 (4.2) 9 (5.7) 3 (2.3) 17 (9.0)a 8 (7.9) 9 (10.3)a 10 (11.1)a 8 (11.9)a 2 (8.7)
Autoimmune endocrine disorder 4 (1.4) 2 (1.3) 2 (1.5) 4 (2.1) 2 (2.0) 2 (2.3) 6 (6.7)a,b 5 (7.5)a,b 1 (4.4)
 Type 1 diabetes 4 (2.1) 2 (2.0) 2 (2.3) 2 (2.2) 2 (3.0)a
 Autoimmune thyroid disease 4 (1.4)a,b 2 (1.3) 2 (1.5)a,b 4 (4.4)a,b 3 (4.5)a,b 1 (4.4)a
  Graves disease 3 (1.0)a,b 1 (0.6) 2 (1.5)a,b 4 (4.4)a,b 3 (4.5)a,b 1 (4.4)a
  Autoimmune thyroiditis 1 (0.4) 1 (0.6)
Autoimmune GI disorder 3 (1.0) 3 (1.9) 7 (3.7)a 2 (2.0) 5 (5.6)a,b
 IBD 3 (1.0) 3 (1.9)c 5 (2.7)a 1 (1.0) 4 (4.6)a,b
 Cholangitis 1 (0.5)a 1 (1.0)a
 Celiac disease 1 (0.5) 1 (1.2)
Autoimmune skin disorder 3 (1.0) 3 (1.9) 3 (1.6) 3 (3.0) 1 (1.1) 1 (1.5)
 Psoriasis 3 (1.0) 3 (1.9) 3 (1.6) 3 (3.0)c 1 (1.1) 1 (1.5)
Rheumatic disease 2 (0.7) 1 (1.2) 1 (0.8) 6 (3.2)a 4 (4.0)c 2 (2.3) 3 (3.3)c 2 (3.0) 1 (4.4)
 RA 2 (1.1) 1 (1.0) 1 (1.2) 1 (1.1) 1 (1.5)
 Systemic CTD 1 (0.4) 1 (0.6) 4 (2.1)a 3 (3.0)a 1 (1.2) 2 (2.2) 1 (1.5) 1 (4.4)c
 Ankylosing spondylitis 1 (0.4) 1 (0.8)c 1 (0.5) 1 (1.0)c

Unless otherwise noted, values are n (%). The numbers are not displayed if no patient had the condition but analysis showed P > 0.10. Autoimmune thyroiditis is often called Hashimoto thyroiditis.

Abbreviations: CTD, connective tissue disorders; GI, gastrointestinal; RA, rheumatoid arthritis.

a

P < 0.05.

b

P < 0.01

c

P = 0.05–0.09.